Motilium not recommended for the risk of sudden death
The High Authority for Health (HAS) recommends not to use domperidone-based drugs, associated with significant risks in children.The High Authority ...
Read moreTag: domperidone
High-dose Motilium soon to be withdrawn from the market
Motilium and other high-dose domperidone-based specialties will be withdrawn from the market on September 10 following a re-evaluation of the ...
Read more
Motilium: Europe wants to restrict its use
The pharmacovigilance committee of the European agency recommends reducing the current authorized doses and no longer prescribing Motilium for heartburn ...
Read more
Motilium, instructions for use
Following the questioning of Prescrire, the Medicines Agency recalls the precautions for the use of Motilium pending its reassessment at ...
Read moreMotilium: the warning from the Medicines Agency
In an analysis, Prescrire brings the number of potential and preventable deaths attributable to motilium to around 120. Because of ...
Read more
Motilium: the cardiac risk confirmed by Europe
The PRAC of the European Medicines Agency is considering measures to limit the risks of medicinal products containing domperidone such ...
Read more
Motilium under surveillance
The European Medicines Agency (EMA) decided this week to re-evaluate the benefit / risk of several specialties including those based ...
Read more